Results 61 to 70 of about 17,364 (243)

The Impact of the US Food and Drug Administration Chlorofluorocarbon Ban on Out-of-pocket Costs and Use of Albuterol Inhalers Among Individuals With Asthma.

open access: yesJAMA Internal Medicine, 2015
IMPORTANCE The US Clean Air Act prohibits use of nonessential ozone-depleting substances. In 2005, the US Food and Drug Administration announced the ban of chlorofluorocarbon (CFC) albuterol inhalers by December 31, 2008.
A. Jena   +3 more
semanticscholar   +1 more source

Assessment of Airway Bronchodilation by Spirometry Compared to Airway Obstruction in Young Children with Asthma

open access: yesCanadian Respiratory Journal, 2016
A reversibility test by an increase of greater than 12% in FEV1 can support a diagnosis of asthma and alter a patient’s treatment plan but may not be applicable to the young ages.
Daphna Vilozni   +5 more
doaj   +1 more source

Nasal high-flow bronchodilator nebulization: a randomized cross-over study

open access: yesAnnals of Intensive Care, 2018
Background There is an absence of controlled clinical data showing bronchodilation effectiveness after nebulization via nasal high-flow therapy circuits. Results Twenty-five patients with reversible airflow obstruction received, in a randomized order: (1)
François Reminiac   +9 more
doaj   +1 more source

Pengaruh Obesitas terhadap Respon Terapi Serangan Asma

open access: yesSari Pediatri, 2018
Latar belakang. Angka kejadian asma pada anak meningkat begitu pula dengan obesitas. Anak obes dengan asma memberi efek mekanik dan keadaan inflamasi.
Rahmawati Rahmawati, Darmawan B Setyanto
doaj   +1 more source

Acute Effects of Albuterol on Ventilatory Capacity in Children with Asthma

open access: yesPediatric Reports
Background: Children with asthma may have a reduced ventilatory capacity, which could lead to symptoms and early termination of a cardiopulmonary exercise test (CPET).
Michael W. H. Wong   +2 more
doaj   +1 more source

Aerosolized albuterol sulfate used as a bronchodilator in horses with recurrent airway obstruction [PDF]

open access: diamond, 1999
Frederik J. Derksen   +6 more
openalex   +1 more source

Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma

open access: yesJournal of Asthma, 2015
Objective: Evaluate the safety of albuterol multidose dry powder inhaler (MDPI), a novel, inhalation-driven device that does not require coordination of actuation with inhalation, in patients with persistent asthma.
G. Raphael   +4 more
semanticscholar   +1 more source

Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study

open access: yesTherapeutic Advances in Respiratory Disease
What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022.
Alberto Papi   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy